DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Primo Chemicals Limited — Amalgamation OR Merger-XBRL

NSE 1 hr ago·25 Sept 2026, 1:53 pm

Primo Chemicals

Primo Chemicals Limited has announced an amalgamation or merger, a process where one company is legally absorbed into another. This strategic move typically aims to combine assets, liabilities, and operations to create a stronger entity.

For investors, such a merger is significant as it can lead to operational synergies and potentially enhanced value. It may also result in changes to the company's shareholding structure and corporate identity, which investors should monitor closely.

Investors should watch for the official scheme details, including the exchange ratio for shares and the timeline for completion. Understanding these terms is crucial to assess how the merger might impact the stock's future performance.